Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.19.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Operating expenses:    
Research and development $ 48,668 $ 28,460
General and administrative 19,223 13,992
Total operating expenses 67,891 42,452
Loss from operations (67,891) (42,452)
Interest and other income, net 1,634 1,009
Net loss (66,257) (41,443)
Unrealized gain (loss) on available-for-sale securities 378 (373)
Comprehensive loss $ (65,879) $ (41,816)
Net loss per common share:    
Basic and diluted net loss per common share $ (1.44) $ (1.05)
Weighted-average shares outstanding used to calculate basic and diluted net loss per common share 46,124 39,596